242 related articles for article (PubMed ID: 31879190)
1. AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis.
Bisserier M; Milara J; Abdeldjebbar Y; Gubara S; Jones C; Bueno-Beti C; Chepurko E; Kohlbrenner E; Katz MG; Tarzami S; Cortijo J; Leopold J; Hajjar RJ; Sassi Y; Hadri L
Mol Ther; 2020 Feb; 28(2):394-410. PubMed ID: 31879190
[TBL] [Abstract][Full Text] [Related]
2. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension.
Bisserier M; Katz MG; Bueno-Beti C; Brojakowska A; Zhang S; Gubara S; Kohlbrenner E; Fazal S; Fargnoli A; Dorfmuller P; Humbert M; Hata A; Goukassian DA; Sassi Y; Hadri L
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502015
[TBL] [Abstract][Full Text] [Related]
3. Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model.
Aguero J; Ishikawa K; Hadri L; Santos-Gallego CG; Fish KM; Kohlbrenner E; Hammoudi N; Kho C; Lee A; Ibáñez B; García-Alvarez A; Zsebo K; Maron BA; Plataki M; Fuster V; Leopold JA; Hajjar RJ
J Am Coll Cardiol; 2016 May; 67(17):2032-46. PubMed ID: 27126531
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
Hadri L; Kratlian RG; Benard L; Maron BA; Dorfmüller P; Ladage D; Guignabert C; Ishikawa K; Aguero J; Ibanez B; Turnbull IC; Kohlbrenner E; Liang L; Zsebo K; Humbert M; Hulot JS; Kawase Y; Hajjar RJ; Leopold JA
Circulation; 2013 Jul; 128(5):512-23. PubMed ID: 23804254
[TBL] [Abstract][Full Text] [Related]
5. Effect of SERCA2a overexpression in the pericardium mediated by the AAV1 gene transfer on rapid atrial pacing in rabbits.
Kuken BN; Aikemu AN; Xiang SY; Wulasihan MH
Genet Mol Res; 2015 Oct; 14(4):13625-32. PubMed ID: 26535677
[TBL] [Abstract][Full Text] [Related]
6. Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1.
Gu X; Han YY; Yang CY; Ji HM; Lan YJ; Bi YQ; Zheng C; Qu J; Cheng MH; Gao J
Pharmacol Res; 2021 Nov; 173():105844. PubMed ID: 34450310
[TBL] [Abstract][Full Text] [Related]
7. Low let-7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis through the TGFβRI/FoxM1/Smad/β-catenin pathway.
Xie H; Gao YM; Zhang YC; Jia MW; Peng F; Meng QH; Wang YC
J Cell Mol Med; 2020 Dec; 24(23):13913-13926. PubMed ID: 33179861
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 is a critical driver of lung fibroblast activation and fibrogenesis.
Penke LR; Speth JM; Dommeti VL; White ES; Bergin IL; Peters-Golden M
J Clin Invest; 2018 Jun; 128(6):2389-2405. PubMed ID: 29733296
[TBL] [Abstract][Full Text] [Related]
9. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
[TBL] [Abstract][Full Text] [Related]
10. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.
Strauss B; Sassi Y; Bueno-Beti C; Ilkan Z; Raad N; Cacheux M; Bisserier M; Turnbull IC; Kohlbrenner E; Hajjar RJ; Hadri L; Akar FG
J Mol Cell Cardiol; 2019 Feb; 127():20-30. PubMed ID: 30502350
[TBL] [Abstract][Full Text] [Related]
11. AAV9-Tspyl2 gene therapy retards bleomycin-induced pulmonary fibrosis by modulating downstream TGF-β signaling in mice.
Zhang S; Tong X; Liu S; Huang J; Zhang L; Zhang T; Wang D; Fan H
Cell Death Dis; 2023 Jun; 14(6):389. PubMed ID: 37391440
[TBL] [Abstract][Full Text] [Related]
12. Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo.
Pulivendala G; Bale S; Godugu C
Toxicol Appl Pharmacol; 2020 Mar; 391():114913. PubMed ID: 32032644
[TBL] [Abstract][Full Text] [Related]
13. Endobronchial Aerosolized AAV1.SERCA2a Gene Therapy in a Pulmonary Hypertension Pig Model: Addressing the Lung Delivery Bottleneck.
Bikou O; Tharakan S; Yamada KP; Kariya T; Aguero J; Gordon A; Mazurek R; Aikawa T; Kohlbrenner E; Fish KM; Hajjar RJ; Ishikawa K
Hum Gene Ther; 2022 May; 33(9-10):550-559. PubMed ID: 35293228
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
Yang J; Zhang X; Li Y; Liu Y
J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
[TBL] [Abstract][Full Text] [Related]
15. miR-627/HMGB1/NF-κB regulatory loop modulates TGF-β1-induced pulmonary fibrosis.
Li J; Kong X; Jiang S; Liao W; Zhang Z; Song J; Liang Y; Zhang W
J Cell Biochem; 2019 Mar; 120(3):2983-2993. PubMed ID: 30536600
[TBL] [Abstract][Full Text] [Related]
16. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways.
Zhang Y; Lu W; Zhang X; Lu J; Xu S; Chen S; Zhong Z; Zhou T; Wang Q; Chen J; Liu P
Pharmacol Res; 2019 Sep; 147():104307. PubMed ID: 31181334
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.
Zsebo K; Yaroshinsky A; Rudy JJ; Wagner K; Greenberg B; Jessup M; Hajjar RJ
Circ Res; 2014 Jan; 114(1):101-8. PubMed ID: 24065463
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.
Huang C; Xiao X; Yang Y; Mishra A; Liang Y; Zeng X; Yang X; Xu D; Blackburn MR; Henke CA; Liu L
J Biol Chem; 2017 Oct; 292(40):16420-16439. PubMed ID: 28726637
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation.
Beeri R; Chaput M; Guerrero JL; Kawase Y; Yosefy C; Abedat S; Karakikes I; Morel C; Tisosky A; Sullivan S; Handschumacher MD; Gilon D; Vlahakes GJ; Hajjar RJ; Levine RA
Circ Heart Fail; 2010 Sep; 3(5):627-34. PubMed ID: 20634484
[TBL] [Abstract][Full Text] [Related]
20. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.
Greenberg B; Butler J; Felker GM; Ponikowski P; Voors AA; Desai AS; Barnard D; Bouchard A; Jaski B; Lyon AR; Pogoda JM; Rudy JJ; Zsebo KM
Lancet; 2016 Mar; 387(10024):1178-86. PubMed ID: 26803443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
